Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000814133-25-000007
Filing Date
2025-02-11
Accepted
2025-02-11 16:32:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 4703
  Complete submission text file 0000814133-25-000007.txt   6779
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Subject) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: SCHEDULE 13G | Act: 34 | File No.: 005-47729 | Film No.: 25610313
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108
Business Address 505 WAKARA WAY 3RD FLOOR SALT LAKE CITY UT 84108 8015330777
WASATCH ADVISORS LP (Filed by) CIK: 0000814133 (see all company filings)

EIN.: 870319391 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G